Homocysteine levels and the risk of osteoporotic fracture.

The Rotterdam Study: objectives and design update. Eur J Epidemiol (2007) 5.78

Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest (2005) 5.19

The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44

The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int (2010) 2.69

Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48

Choline: an essential nutrient for public health. Nutr Rev (2009) 1.97

Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study. Nutr J (2007) 1.77

Homocysteine and osteoporotic fractures--culprit or bystander? N Engl J Med (2004) 1.74

A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol (2006) 1.68

Detection of homocysteine and cysteine. J Am Chem Soc (2005) 1.48

Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol (2008) 1.45

Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int (2007) 1.38

Mouse models of cystathionine beta-synthase deficiency reveal significant threshold effects of hyperhomocysteinemia. FASEB J (2008) 1.32

Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab (2012) 1.27

Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc (2008) 1.24

The treatment of hyperhomocysteinemia. Annu Rev Med (2009) 1.23

Reductions in degree of mineralization and enzymatic collagen cross-links and increases in glycation-induced pentosidine in the femoral neck cortex in cases of femoral neck fracture. Osteoporos Int (2006) 1.23

Do proton pump inhibitors decrease calcium absorption? J Bone Miner Res (2010) 1.21

The association of bone mineral density measures with incident cardiovascular disease in older adults. Osteoporos Int (2007) 1.19

Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol (2012) 1.18

The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am J Clin Nutr (2007) 1.16

A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet (2005) 1.15

Homocysteine imbalance: a pathological metabolic marker. Adv Nutr (2012) 1.14

Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation (2009) 1.14

Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int (2012) 1.13

Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation. J Biol Chem (2010) 1.12

Regulation of gene expression by 1,25-dihydroxyvitamin D3 in bone cells: exploiting new approaches and defining new mechanisms. Bonekey Rep (2014) 1.10

Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am J Clin Nutr (2013) 1.08

Vitamin B12 in health and disease. Nutrients (2010) 1.07

Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab (2008) 1.05

Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab (2008) 1.02

Hydrogen sulfide maintains mesenchymal stem cell function and bone homeostasis via regulation of Ca(2+) channel sulfhydration. Cell Stem Cell (2014) 1.01

Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease. Antioxid Redox Signal (2007) 1.01

Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr (2011) 1.00

Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia. Osteoporos Int (2009) 1.00

Accurate assessment and identification of naturally occurring cellular cobalamins. Clin Chem Lab Med (2008) 0.99

Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab (2009) 0.98

1,25-dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3-E1 cells by direct regulation of cystathionine β-synthase. J Bone Miner Res (2011) 0.97

Homocysteine metabolism in ZDF (type 2) diabetic rats. Diabetes (2005) 0.96

Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone (2006) 0.96

Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia. Invest Ophthalmol Vis Sci (2015) 0.95

Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int (2007) 0.94

Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med Sci (2007) 0.94

Vitamin B12, folate, homocysteine, and bone health in adults and elderly people: a systematic review with meta-analyses. J Nutr Metab (2013) 0.93

Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int (2012) 0.93

The contribution of collagen crosslinks to bone strength. Bonekey Rep (2012) 0.92

Involvement of endoplasmic reticulum stress in homocysteine-induced apoptosis of osteoblastic cells. J Bone Miner Metab (2012) 0.91

Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Gut (2005) 0.91

Biochemical assessment of bone turnover and bone fragility in men. Osteoporos Int (2007) 0.90

Homocysteine and mobility in older adults. J Am Geriatr Soc (2010) 0.88

The Association of Higher Plasma Macrophage Migration Inhibitory Factor Levels with Lower Bone Mineral Density and Higher Bone Turnover Rate in Postmenopausal Women. Endocrinol Metab (Seoul) (2016) 0.88

Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab (2010) 0.87

Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistry. Curr Osteoporos Rep (2014) 0.87

Stimulation of osteoblast activity by homocysteine. J Cell Mol Med (2008) 0.87

Hyperhomocysteinemia decreases bone blood flow. Vasc Health Risk Manag (2011) 0.86

The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures. J Bone Miner Metab (2008) 0.85

The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int (2008) 0.85

The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial. BMC Geriatr (2013) 0.85

T3 affects expression of collagen I and collagen cross-linking in bone cell cultures. Biochem Biophys Res Commun (2010) 0.85

Effect of ibandronate therapy on serum homocysteine and leptin in postmenopausal osteoporotic females. Osteoporos Int (2014) 0.85

Dll1 haploinsufficiency in adult mice leads to a complex phenotype affecting metabolic and immunological processes. PLoS One (2009) 0.85

Plasma homocysteine level and hepatic sulfur amino acid metabolism in mice fed a high-fat diet. Eur J Nutr (2012) 0.84

The association between high plasma homocysteine levels and lower bone mineral density in Slovak women: the impact of vegetarian diet. Eur J Nutr (2009) 0.84

Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial. Calcif Tissue Int (2015) 0.83

Relationship of circulating total homocysteine and C-reactive protein to trabecular bone in postmenopausal women. J Clin Densitom (2007) 0.83

Homocysteine transport by human aortic endothelial cells: identification and properties of import systems. Arch Biochem Biophys (2006) 0.83

B vitamins, homocysteine and bone health. Nutrients (2015) 0.83

Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients. J Bone Miner Metab (2009) 0.83

Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency. J Bone Miner Res (2015) 0.82

Homocysteine and familial longevity: the Leiden Longevity Study. PLoS One (2011) 0.81

Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with spinal BMD in 9-year-old children. J Bone Miner Res (2009) 0.81

Association of red blood cell 5-methyltetrahydrofolate folate with bone mineral density in postmenopausal Iranian women. Osteoporos Int (2005) 0.80

Nutritional concerns, health and survival in old age. Biogerontology (2010) 0.80

Association between methylenetetrahydrofolate reductase C677T polymorphism and bone mineral density: the Dong-gu Study and the Namwon Study. J Korean Med Sci (2013) 0.79

Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. Eur J Nutr (2004) 0.79

Relation of plasma total homocysteine, folate and vitamin B12 levels to bone mineral density in Moroccan healthy postmenopausal women. Rheumatol Int (2010) 0.79

The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study. J Clin Med Res (2015) 0.79

Design of a randomized clinical trial of concurrent treatment with vitamin K2 and risedronate compared to risedronate alone in osteoporotic patients: Japanese Osteoporosis Intervention Trial-03 (JOINT-03). J Bone Miner Metab (2013) 0.78

Variation in the MC4R gene is associated with bone phenotypes in elderly Swedish women. PLoS One (2014) 0.78

Effect of B vitamin (folate, B6, and B12) supplementation on osteoporotic fracture and bone turnover markers: a meta-analysis. Med Sci Monit (2015) 0.78

Abnormally activated one-carbon metabolic pathway is associated with mtDNA hypermethylation and mitochondrial malfunction in the oocytes of polycystic gilt ovaries. Sci Rep (2016) 0.78

Changes in bone mineral density and body composition of children with well-controlled homocystinuria caused by CBS deficiency. Osteoporos Int (2013) 0.78

The association between oxidative stress and bone mineral density according to menopausal status of Korean women. Obstet Gynecol Sci (2015) 0.77

Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia. Epigenetics (2012) 0.77

The Longitudinal Aging Study Amsterdam: cohort update 2016 and major findings. Eur J Epidemiol (2016) 0.77

The out-of-focus bias in drug surveillance. Eur J Clin Pharmacol (2012) 0.77

The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment. Ital J Pediatr (2014) 0.77

Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women. Rheumatol Int (2008) 0.77

Effect of folic acid on bone metabolism: a randomized double blind clinical trial in postmenopausal osteoporotic women. Daru (2014) 0.77

Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention. Stroke Res Treat (2013) 0.77

Metabolic syndrome and osteoporotic fracture: a population-based study in China. BMC Endocr Disord (2016) 0.76

The relation of plasma homocysteine to radiographic knee osteoarthritis. Osteoarthritis Cartilage (2008) 0.76

Role of homocysteinylation of ACE in endothelial dysfunction of arteries. Am J Physiol Heart Circ Physiol (2014) 0.76

Cystathionine γ-Lyase-Hydrogen Sulfide Induces Runt-Related Transcription Factor 2 Sulfhydration, Thereby Increasing Osteoblast Activity to Promote Bone Fracture Healing. Antioxid Redox Signal (2017) 0.76

Homocysteine as a Pathological Biomarker for Bone Disease. J Cell Physiol (2016) 0.76

Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: physical and biochemical characteristics. Osteoporos Int (2005) 0.75

Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med (2004) 0.75

B-vitamin status and bone mineral density and risk of lumbar osteoporosis in older females in the United States. Am J Clin Nutr (2015) 0.75

Hydrogen Sulfide Regulates Homeostasis of Mesenchymal Stem Cells and Regulatory T Cells. J Dent Res (2016) 0.75

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61

Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16

Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA (2004) 9.55

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Incidental findings on brain MRI in the general population. N Engl J Med (2007) 8.59

Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet (2009) 8.42

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation (2006) 8.18

Epidemiology of Parkinson's disease. Lancet Neurol (2006) 8.13

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis (2008) 7.45

Estimates of optimal vitamin D status. Osteoporos Int (2005) 7.13

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J (2006) 6.31

Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc (2012) 6.19

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

The Rotterdam Study: objectives and design update. Eur J Epidemiol (2007) 5.78

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol (2006) 5.39

Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet (2002) 5.32

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20

Correlation between genetic and geographic structure in Europe. Curr Biol (2008) 5.02

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens (2003) 4.91

Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90

Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78

Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke (2003) 4.78

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol (2006) 4.77

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care (2007) 4.69

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Genetics and biology of vitamin D receptor polymorphisms. Gene (2004) 4.60

Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet (2009) 4.56

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37